The new global pharma order: Trump, China and Europe's uncertain future

Acacia 1&2

Life Sciences Stream

Information

2025 disrupted the global pharmaceutical sector, and 2026 will challenge companies on pricing, innovation, and manufacturing across key markets. Uncover a high-level outlook meeting boardroom insight, highlighting the trends and opportunities shaping pharma investment and strategy.

ING Wholesale Banking

ING Meeting Suite 24

ING Wholesale Banking meets all banking needs of large corporations, multinationals and financial institutions. With a history that stretches back some 200 years, we have made a name for ourselves by helping clients build successful businesses. We do this by ensuring we understand their unique needs, by being a trusted advisor to them for the long term and by proactively creating innovative solutions and executing them flawlessly. In addition to the basic banking services of lending, payments & cash management and treasury, we provide tailored banking solutions in areas including corporate finance, leasing, structured finance, commercial finance (factoring), equity markets and debt capital markets. In short, we can finance your growth, manage your day-to-day banking needs and provide you with a full range of banking solutions to help you achieve your business goals. We can help you manage your business risks more effectively, and grow with more confidence. We are a truly international team of more than 11,000 banking professionals with local knowledge and a presence in 40 countries.

Speakers

Diederik Stadig

Senior Economist, Healthcare & PharmaING

Associate Director and Head of the Health and Societal Resilience ProgrammeEuropean Policy Centre

Stephen Farrelly

Managing Director, Global Lead Healthcare & PharmaING

Documents & Links

Europe’s last chance to revive its pharmaceutical innovation power
Europe’s pharmaceutical industry needs to make sure it doesn't become yesterday's news. It can become a powerhouse once again, but it needs to act fast.
OpenEurope’s last chance to revive its pharmaceutical innovation power
The new global pharma order, ING
OpenThe new global pharma order, ING

Registered attendees

Cédric Degryse

DirectorGHO Capital Partners

Christine Donaldson

President & CEOHealthPRO Canada